Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
US-9216180-B2 · Dec 22, 2015 · US
Compositions and methods for treating cancer
US9060993B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9060993-B2 |
| Application number | US-55622004-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 7, 2004 |
| Priority date | May 9, 2003 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods of treating individuals identified as having cancer using ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of inducing apoptosis in cancer cells using an ATP citrate lyase inhibitor and/or tri-carboxylate transporter inhibitor are disclosed. of treating an individual who has cancer comprising the steps of identifying the cancer as having a high rate of aerobic glycolysis, and administering an ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of treating individuals who have cancer using compounds that inhibit the expression of ATP citrate lyase or tricarboxylate transporter are disclosed. Methods of identifying a compound with anticancer activity are disclosed.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating an individual who has cancer that comprises cancer cells that have a high rate of aerobic glycolysis, the method comprising the steps of: identifying said cancer as a cancer that comprises cancer cells that have a high rate of aerobic glycolysis, wherein said cancer is determined to be a cancer that comprises cancer cells that have a high rate of aerobic glycolysis by PET imaging using 18 fluoro-deoxyglucose, and subsequently administ…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K31/34Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9060993B2 cover?
- Methods of treating individuals identified as having cancer using ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. Methods of inducing apoptosis in cancer cells using an ATP citrate lyase inhibitor and/or tri-carboxylate transporter inhibitor are disclosed. of treating an individual who has cancer comprising the steps of identifying the cancer as having a h…
- Who is the assignee on this patent?
- Thompson Craig B, Bauer Daniel, Hatzivassiliou Georgia, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/34. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).